Bausch Health Companies Inc [BHC] stock is trading at $6.61, up 12.03%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHC shares have gain 3.61% over the last week, with a monthly amount drifted -0.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bausch Health Companies Inc [NYSE: BHC] stock has seen the most recent analyst activity on August 02, 2024, when Piper Sandler downgraded its rating to a Underweight and also revised its price target to $3 from $9. Previously, Raymond James started tracking the stock with Mkt Perform rating on July 10, 2024, and set its price target to $8. On September 20, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $16 on the stock. TD Cowen downgraded its rating to a Market Perform. Truist downgraded its rating to a Hold. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on July 29, 2022, and downed its price target to $5. In a note dated July 28, 2022, JP Morgan downgraded an Neutral rating on this stock.
Bausch Health Companies Inc [BHC] stock has fluctuated between $4.25 and $9.85 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Bausch Health Companies Inc [NYSE: BHC] shares were valued at $6.61 at the most recent close of the market. An investor can expect a potential return of 51.29% based on the average BHC price forecast.
Analyzing the BHC fundamentals
Bausch Health Companies Inc [NYSE:BHC] reported sales of 10.03B for the trailing twelve months, which represents a growth of 6.81%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.38 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.18 points at the first support level, and at 5.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.98, and for the 2nd resistance point, it is at 7.36.
Ratios To Look Out For
For context, Bausch Health Companies Inc’s Current Ratio is 1.31. As well, the Quick Ratio is 0.98, while the Cash Ratio is 0.27. Considering the valuation of this stock, the price to sales ratio is 0.24 and price to earnings (TTM) ratio is 6.80.
Transactions by insiders
Recent insider trading involved Carson Seana, EVP, General Counsel, that happened on Sep 08 ’25 when 13370.0 shares were sold. Officer, Carson Seana completed a deal on Sep 08 ’25 to buy 13370.0 shares. Meanwhile, Director Lee Frank D. sold 15912.0 shares on Aug 21 ’25.
